RCMNY
ANIP icon

Rubric Capital Management (New York)’s ANI Pharmaceuticals ANIP Stock Holding History

Rubric Capital Management (New York)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-343,414
Closed -$31.5M – 78
2025
Q3 		$31.5M Buy
343,414
+85,745
+33% +$6.99M 0.35% 48
2025
Q2 		$16.8M Buy
257,669
+200,998
+355% +$13.1M 0.25% 56
2025
Q1 		$3.79M Hold
56,671
– – 0.07% 59
2024
Q4 		$3.13M Hold
56,671
– – 0.04% 65
2024
Q3 		$3.38M Sell
56,671
-547,129
-91% -$33.4M 0.06% 59
2024
Q2 		$38.4M Sell
603,800
-354,733
-37% -$23M 1.01% 38
2024
Q1 		$66.3M Sell
958,533
-166,467
-15% -$10M 1.96% 18
2023
Q4 		$62M Buy
1,125,000
+277,989
+33% +$15.3M 1.29% 12
2023
Q3 		$49.2M Hold
847,011
– – 1.84% 19
2023
Q2 		$45.6M Buy
847,011
+198,970
+31% +$8.82M 1.95% 22
2023
Q1 		$25.7M Buy
648,041
+271,909
+72% +$11.5M 0.67% 37
2022
Q4 		$15.1M Buy
376,132
+89,086
+31% +$3.35M 0.66% 44
2022
Q3 		$9.23M Buy
287,046
+204,602
+248% +$7M 0.46% 46
2022
Q2 		$2.45M Buy
+82,444
New +$2.38M 0.13% 75
2022
Q1 		– Sell
-307,557
Closed -$14.2M – 73
2021
Q4 		$14.2M Buy
+307,557
New +$13.2M 0.67% 42

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Rubric Capital Management (New York)'s ANIP Position: Q4 2025 in Review

Rubric Capital Management (New York) sold out of ANI Pharmaceuticals (ANIP) in Q4 2025, closing a stake of 343,414 shares — an estimated $31.5M sold.

Rubric Capital Management (New York) first reported a position in ANIP in Q4 2021 and held it in 15 quarters. The position peaked at $66.3M in Q1 2024. 284 funds tracked by Wall St. Rank hold ANIP as of Q4 2025.

  • Rubric Capital Management (New York) reported no remaining ANI Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Rubric Capital Management (New York) sold 343,414 ANI Pharmaceuticals shares in Q4 2025, an estimated $31.5M.
  • Rubric Capital Management (New York) first reported a position in ANI Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Rubric Capital Management (New York)'s ANI Pharmaceuticals position peaked at $66.3M in Q1 2024.
  • 284 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2025.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.